-
Additional file 1: Table S1. of The GRADE evidence-to-decision framework: a r...
GRADE Evidence to Decision (EtD) Framework example. (DOC 188 kb) -
Additional file 3: of Quality of reporting of outcomes in phase III studies o...
Venn diagrams summarising all reported outcomes according to the sensitivity analysis (i.e. pre- and post-CONSORT). (PPTX 80 kb) -
Additional file 1: of Successful contemporary reverse controlled antegrade an...
Timeline of the Clinical Course. (DOCX 15 kb) -
dedup_wf_001--4c86a99ca7db4de80c6c0eb1e303beef
Additional file 4: Fig. S1. Survival curves according to whether the patients received palliative chemotherapy or best supportive care. Kaplanâ Meier curve of progression-free... -
Additional file 5: of Acceptability of healthcare interventions: an overview ...
When was acceptability assessed?. Description of data: Summary of the timing of acceptability assessments relative to start of intervention reported in the papers identified in... -
Additional file 2: of Development of a quality indicator set to measure and i...
Questionnaire round 2. (DOCX 79 kb) -
MOESM1 of Intact neural representations of affective meaning of touch but lac...
Additional file 1: Figure S1. Intra-subject, and inter-subject consistency. Table S1. The strength and direction of a linear relationship between the social touch behavior and... -
Additional file 5: of The risk associated with spinal manipulation: an overvi...
Reference lists for the included reviews in the overview. (PDF 177 kb) -
Additional file 1 of Factors associated with intraoperative extracorporeal me...
Additional file 1 Figure 4. Process reports intraoperative ECMO support in LTX patients. PA (pulmonary artery); LTX (lung transplantation). -
dedup_wf_001--7feaae43374e02df0ea0abe0f4652a28
Additional file 1: Table S1. Associations of maternal smoking during pregnancy with term birth weight and the risk of being SGA; overall and in strata of pre-pregnancy... -
Additional file 5: of A review of patient-reported outcome measures to assess...
PROs excluded from detailed analysis. Table listing each identified PRO excluded from detailed analysis, detailing each PRO acronym, PRO name, no. studies identified as using... -
How to do a pre-review
This material presented at "Workshop Manajemen Publikasi Berbasis OJS (Submit, Review, Editing, Publish)" in Universitas Widya Dharma, August 31st 2019 This session talks... -
Additional file 2: of Use of health outcome and health service utilization in...
Evaluation of health services utilization indicators. This box presents the detailed evaluation made about each indicator of health services utilization outcome from the papers... -
dedup_wf_001--cbd937420269b10d034fcd8bc49cbfda
Additional file 2. GP interview topic guide. TDF-based topic guide used during GP interviews that was used to explore theoretical domains as barriers and facilitators to... -
dedup_wf_001--c6c1dd673999691a8676a1c91913da57
Roundtable Agenda. Description of data: Content of discussion during the 2Â day research roundtable data collection component. (DOCX 17 kb) -
Additional file 4: Table S3. of Nano-risk Science: application of toxicogenom...
Details of rodent studies considered by NIOSH in calculating points of departure (PODs). (DOCX 15Â kb) -
Additional file 1: Table S1. of Job satisfaction and motivation among public ...
Cronbachâ s Alpha of motivation indices by survey round. Cronbachâ s alpha was used to examine the inter-reliability of the scales used and most of the scales had acceptable... -
dedup_wf_001--392f4c72af42e16ca1668efb6e5edcac
Table S3. Summary of adverse events reported in patients who started treatment at or after Hunter Outcome Survey (HOS) entry (DOCX 25 kb) -
Additional file 3: of Long-term adverse event profile from four completed tri...
Ethics Committees for the Eliglustat Clinical Trials. (PDF 91 kb) -
dedup_wf_001--30da7b45b70869646bef069fc6710d0d
Table S1. The groups of hormone treatment (nmol/L) (DOCX 15â kb)
